Non-invasive diagnostics of neurodegenerative diseases: clinical significance of retinal screening
Keywords:
Alzheimer’s disease, retinal biomarkers, Amyloid-beta, optical coherence tomography (OCT), hyperspectral imaging, neurodegeneration, non-invasive diagnostics, screening, cognitive declineAbstract
In recent years, the early diagnosis of Alzheimer’s disease has become one of the most important challenges in modern medicine. Recent studies suggest that the retina, as a part of the central nervous system, can reflect pathological changes occurring in the brain. In particular, Amyloid-beta and other neurodegenerative alterations can also be detected in the retina. This article analyzes the diagnostic potential of retinal biomarkers, optical coherence tomography (OCT), and hyperspectral imaging technologies. The findings highlight the prospects for developing non-invasive, cost-effective, and large-scale screening methods.
References
1. London A, Benhar I, Schwartz M. The retina as a window to the brain—from eye research to CNS disorders. Nat Rev Neurol. 2025.
2. Lim JK, Li QX, He Z, et al. Retinal biomarkers for early detection of Alzheimer kasalligi. Prog Retin Eye Res. 2026.
3. Hadoux X, Hui F, Lim JK, et al. Non-invasive in vivo hyperspectral imaging of retinal biomarkers in Alzheimer’s disease. Alzheimers Dement. 2025.
4. Cheung CY, Ong YT, Ikram MK, et al. Microvascular changes in the retina and their association with cognitive decline. Ophthalmology. 2025.
5. den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer’s disease: A systematic review and meta-analysis.Alzheimers Dement. 2025.
6. Santos CY, Johnson LN, Sinoff SE, et al. Change in retinal structural and functional
measures in Alzheimer’s disease. J Alzheimers Dis. 2025.
7. Chan VTT, Sun Z, Tang S, et al. Spectral-domain optical coherence tomography in Alzheimer’s disease: A systematic review. Surv Ophthalmol. 2025.
8. Gupta VK, Chitranshi N, Gupta VB, et al. Amyloid beta accumulation and its role in retinal degeneration. Mol Neurobiol. 2025.
9. Snyder PJ, Alber J, Alt C, et al. Retinal imaging in Alzheimer’s and neurodegenerative diseases. Alzheimers Dement. 2025.
10. Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M. Ocular indicators of Alzheimer’s: Exploring the eye-brain connection. Acta Neuropathol. 2025.
